-
1
-
-
0037087144
-
Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US adult MDS Clinical Trials Group
-
Sherman KE, Rouster SD, Chung RT, et al. 2002. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult MDS Clinical Trials Group. Clin. Infect. Dis. 34:831-37
-
(2002)
Clin. Infect. Dis
, vol.34
, pp. 831-837
-
-
Sherman, K.E.1
Rouster, S.D.2
Chung, R.T.3
-
2
-
-
0038386036
-
Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the D:A:D study
-
Friis-Moller N, Weber R, Reiss P, et al. 2003. Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the D:A:D study. AIDS 17:1179-93
-
(2003)
AIDS
, vol.17
, pp. 1179-1193
-
-
Friis-Moller, N.1
Weber, R.2
Reiss, P.3
-
3
-
-
0037418113
-
Hepatitis C in the HIV-infected person
-
Sulkowski MS, Thomas DL. 2003. Hepatitis C in the HIV-infected person. Ann. Intern. Med. 138:197-207
-
(2003)
Ann. Intern. Med
, vol.138
, pp. 197-207
-
-
Sulkowski, M.S.1
Thomas, D.L.2
-
4
-
-
0027996992
-
Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: Final report from a longitudinal study
-
Gerberding JL. 1994. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J. Infect. Dis. 170:1410-17
-
(1994)
J. Infect. Dis
, vol.170
, pp. 1410-1417
-
-
Gerberding, J.L.1
-
5
-
-
0033023854
-
Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection
-
Villano SA, Vlahov D, Nelson KE, et al. 1999. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 29:908-14
-
(1999)
Hepatology
, vol.29
, pp. 908-914
-
-
Villano, S.A.1
Vlahov, D.2
Nelson, K.E.3
-
6
-
-
28944432316
-
Clinical presentation and course of acute hepatitis C infection in HIV-infected patients
-
Luetkemeyer A, Hare CB, Stansell J, et al. 2006. Clinical presentation and course of acute hepatitis C infection in HIV-infected patients. J Acquir. Immune Defic. Syndr. 41:31-36
-
(2006)
J Acquir. Immune Defic. Syndr
, vol.41
, pp. 31-36
-
-
Luetkemeyer, A.1
Hare, C.B.2
Stansell, J.3
-
7
-
-
34247605911
-
Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours
-
Danta M, Brown D, Bhagani S, et al. 2007. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS 21:983-91
-
(2007)
AIDS
, vol.21
, pp. 983-991
-
-
Danta, M.1
Brown, D.2
Bhagani, S.3
-
8
-
-
39649094195
-
-
Poster 130, Los Angeles, CA, Feb. 25-28
-
Fischer M, Richardson D, Sabin C. 2007. Poster 130. Conf. Retroviruses Opportunistic Infect., 14th, Los Angeles, CA, Feb. 25-28
-
(2007)
Conf. Retroviruses Opportunistic Infect., 14th
-
-
Fischer, M.1
Richardson, D.2
Sabin, C.3
-
9
-
-
79960391970
-
Hepatitis C virus infection in a large cohort of homosexually active men: Independent associations with HIV-1 infection and injecting drug use but not sexual behaviour
-
Bodsworth NJ, Cunningham P, Kaldor J, et al. 1996. Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour. Genitourin. Med. 72:118-22
-
(1996)
Genitourin. Med
, vol.72
, pp. 118-122
-
-
Bodsworth, N.J.1
Cunningham, P.2
Kaldor, J.3
-
10
-
-
34447539217
-
Reconstruction of the hepatitis C virus epidemic in the US hemophilia population, 1940-1990
-
Goedert JJ, Chen BE, Preiss L, et al. 2007. Reconstruction of the hepatitis C virus epidemic in the US hemophilia population, 1940-1990. Am. J. Epidemiol. 165:1443-53
-
(2007)
Am. J. Epidemiol
, vol.165
, pp. 1443-1453
-
-
Goedert, J.J.1
Chen, B.E.2
Preiss, L.3
-
11
-
-
0026043177
-
Heterosexual cotransmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV)
-
Eyster ME, Alter HJ, Aledort LM, et al. 1991. Heterosexual cotransmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann. Intern. Med. 115:764-68
-
(1991)
Ann. Intern. Med
, vol.115
, pp. 764-768
-
-
Eyster, M.E.1
Alter, H.J.2
Aledort, L.M.3
-
12
-
-
0028801508
-
Mother-to-infant transmission of hepatitis C virus
-
Zanetti AR, Tanzi E, Paccagnini S, et al. 1995. Mother-to-infant transmission of hepatitis C virus. Lancet 345:289-91
-
(1995)
Lancet
, vol.345
, pp. 289-291
-
-
Zanetti, A.R.1
Tanzi, E.2
Paccagnini, S.3
-
13
-
-
16944364046
-
Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers
-
Hershow RC, Riester KA, Lew J, et al. 1997. Increased vertical transmission of human immunodeficiency virus from hepatitis C virus-coinfected mothers. J. Infect. Dis. 176:414-20
-
(1997)
J. Infect. Dis
, vol.176
, pp. 414-420
-
-
Hershow, R.C.1
Riester, K.A.2
Lew, J.3
-
14
-
-
17344364927
-
Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers
-
Thomas DL, Villano SA, Riester KA, et al. 1998. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. J. Infect. Dis. 177:1480-88
-
(1998)
J. Infect. Dis
, vol.177
, pp. 1480-1488
-
-
Thomas, D.L.1
Villano, S.A.2
Riester, K.A.3
-
15
-
-
0034718227
-
The natural history of hepatitis C virus infection: Host, viral, and environmental factors
-
Thomas DL, Astemborski J, Rai RM, et al. 2000. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 284:450-56
-
(2000)
JAMA
, vol.284
, pp. 450-456
-
-
Thomas, D.L.1
Astemborski, J.2
Rai, R.M.3
-
16
-
-
0037181727
-
Protection against persistence of hepatitis C
-
Mehta SH, Cox A, Hoover DR, et al. 2002. Protection against persistence of hepatitis C. Lancet 359:1478-83
-
(2002)
Lancet
, vol.359
, pp. 1478-1483
-
-
Mehta, S.H.1
Cox, A.2
Hoover, D.R.3
-
17
-
-
0029791087
-
Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users
-
Thomas DL, Shih JW, Alter HJ, et al. 1996. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J. Infect. Dis. 174:690-95
-
(1996)
J. Infect. Dis
, vol.174
, pp. 690-695
-
-
Thomas, D.L.1
Shih, J.W.2
Alter, H.J.3
-
18
-
-
0036721470
-
End-stage liver disease in persons with hemophilia and transfusion-associated infections
-
Goedert JJ, Eyster ME, Lederman MM, et al. 2002. End-stage liver disease in persons with hemophilia and transfusion-associated infections. Blood 100:1584-89
-
(2002)
Blood
, vol.100
, pp. 1584-1589
-
-
Goedert, J.J.1
Eyster, M.E.2
Lederman, M.M.3
-
19
-
-
0028129404
-
Increasing hepatitis C virus RNA levels in hemophiliacs: Relationship to human immunodeficiency virus infection and liver disease
-
Eyster ME, Fried MW, Di Bisceglie AM, et al. 1994. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Blood 84:1020-23
-
(1994)
Blood
, vol.84
, pp. 1020-1023
-
-
Eyster, M.E.1
Fried, M.W.2
Di Bisceglie, A.M.3
-
20
-
-
0037183911
-
Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in coinfected subjects
-
Chung RT, Evans SR, Yang Y, et al. 2002. Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in coinfected subjects. AIDS 16:1915-23
-
(2002)
AIDS
, vol.16
, pp. 1915-1923
-
-
Chung, R.T.1
Evans, S.R.2
Yang, Y.3
-
21
-
-
0035882187
-
Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis
-
Graham CS, Baden LR, Yu E, et al. 2001. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin. Infect. Dis. 33:562-69
-
(2001)
Clin. Infect. Dis
, vol.33
, pp. 562-569
-
-
Graham, C.S.1
Baden, L.R.2
Yu, E.3
-
22
-
-
0035112776
-
Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection
-
Bica I, McGovern B, Dhar R, et al. 2001. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin. Infect. Dis. 32:492-97
-
(2001)
Clin. Infect. Dis
, vol.32
, pp. 492-497
-
-
Bica, I.1
McGovern, B.2
Dhar, R.3
-
23
-
-
33846991954
-
Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study)
-
Rosenthal E, Pialoux G, Bernard N, et al. 2007. Liver-related mortality in human-immunodeficiency-virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study). J. Viral Hepat. 14:183-88
-
(2007)
J. Viral Hepat
, vol.14
, pp. 183-188
-
-
Rosenthal, E.1
Pialoux, G.2
Bernard, N.3
-
24
-
-
85062055676
-
Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D study
-
Weber R, Sabin CA, Friis-Moller N, et al. 2006. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch. Intern. Med. 166:1632-41
-
(2006)
Arch. Intern. Med
, vol.166
, pp. 1632-1641
-
-
Weber, R.1
Sabin, C.A.2
Friis-Moller, N.3
-
25
-
-
33846904554
-
Survival of persons with and without HIV infection in Denmark, 1995-2005
-
Lohse N, Hansen AB, Pedersen G, et al. 2007. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann. Intern. Med. 146:87-95
-
(2007)
Ann. Intern. Med
, vol.146
, pp. 87-95
-
-
Lohse, N.1
Hansen, A.B.2
Pedersen, G.3
-
26
-
-
33749175714
-
Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City
-
Sackoff JE, Hanna DB, Pfeiffer MR, et al. 2006. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann. Intern. Med. 145:397-406
-
(2006)
Ann. Intern. Med
, vol.145
, pp. 397-406
-
-
Sackoff, J.E.1
Hanna, D.B.2
Pfeiffer, M.R.3
-
27
-
-
0034679085
-
Elevated liver enzymes following initiation of antiretroviral therapy
-
Sulkowski MS, Thomas DL, Chaisson RE, et al. 2000. Elevated liver enzymes following initiation of antiretroviral therapy. JAMA 283:2526-27
-
(2000)
JAMA
, vol.283
, pp. 2526-2527
-
-
Sulkowski, M.S.1
Thomas, D.L.2
Chaisson, R.E.3
-
28
-
-
33746059779
-
Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients
-
McGovern BH, Ditelberg JS, Taylor LE, et al. 2006. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients. Clin. Infect. Dis. 43:365-72
-
(2006)
Clin. Infect. Dis
, vol.43
, pp. 365-372
-
-
McGovern, B.H.1
Ditelberg, J.S.2
Taylor, L.E.3
-
29
-
-
0029052336
-
Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alfa: Case report and literature review
-
Khella SL, Frost S, Hermann GA, et al. 1995. Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alfa: case report and literature review. Neurology 45:407-11
-
(1995)
Neurology
, vol.45
, pp. 407-411
-
-
Khella, S.L.1
Frost, S.2
Hermann, G.A.3
-
30
-
-
0032837102
-
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group
-
Benhamou Y, Bochet M, Di Martino V, et al. 1999. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 30:1054-58
-
(1999)
Hepatology
, vol.30
, pp. 1054-1058
-
-
Benhamou, Y.1
Bochet, M.2
Di Martino, V.3
-
31
-
-
28844509556
-
Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy
-
Brau N, Salvatore M, Rios-Bedoya CF, et al. 2006. Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J. Hepatol. 44:47-55
-
(2006)
J. Hepatol
, vol.44
, pp. 47-55
-
-
Brau, N.1
Salvatore, M.2
Rios-Bedoya, C.F.3
-
32
-
-
0344120830
-
Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C coinfection
-
Qurishi N, Kreuzberg C, Luchters G, et al. 2004. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C coinfection. Lancet 362:1708-13
-
(2004)
Lancet
, vol.362
, pp. 1708-1713
-
-
Qurishi, N.1
Kreuzberg, C.2
Luchters, G.3
-
33
-
-
1842479859
-
Diagnosis, management, and treatment of hepatitis C
-
Strader DB, Wright T, Thomas DL, et al. 2004. Diagnosis, management, and treatment of hepatitis C. Hepatology 39:1147-71
-
(2004)
Hepatology
, vol.39
, pp. 1147-1171
-
-
Strader, D.B.1
Wright, T.2
Thomas, D.L.3
-
34
-
-
20144389653
-
-
Alberti A, Clumeck N, Collins S, et al. 2005. Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV-coinfected patients. J. Hepatol. 42:615-24
-
Alberti A, Clumeck N, Collins S, et al. 2005. Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV-coinfected patients. J. Hepatol. 42:615-24
-
-
-
-
35
-
-
0033058754
-
Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon
-
Reichard O, Glaumann H, Fryden A, et al. 1999. Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon. J. Hepatol. 30:783-87
-
(1999)
J. Hepatol
, vol.30
, pp. 783-787
-
-
Reichard, O.1
Glaumann, H.2
Fryden, A.3
-
36
-
-
11144252248
-
Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies
-
Soriano V, Maida I, Nunez M, et al. 2004. Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies. Antivir. Ther. 9:987-92
-
(2004)
Antivir. Ther
, vol.9
, pp. 987-992
-
-
Soriano, V.1
Maida, I.2
Nunez, M.3
-
37
-
-
33646895462
-
Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients
-
Dominguez S, Ghosn J, Valantin MA, et al. 2006. Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients. AIDS 20:1157-61
-
(2006)
AIDS
, vol.20
, pp. 1157-1161
-
-
Dominguez, S.1
Ghosn, J.2
Valantin, M.A.3
-
38
-
-
10344230440
-
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: A randomized controlled trial
-
Carrat F, Bani-Sadr F, Pol S, et al. 2004. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 292:2839-48
-
(2004)
JAMA
, vol.292
, pp. 2839-2848
-
-
Carrat, F.1
Bani-Sadr, F.2
Pol, S.3
-
39
-
-
3343012408
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients
-
Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al. 2004. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N. Engl. J. Med. 351:438-50
-
(2004)
N. Engl. J. Med
, vol.351
, pp. 438-450
-
-
Torriani, F.J.1
Rodriguez-Torres, M.2
Rockstroh, J.K.3
-
40
-
-
3342892905
-
Peginterferon alfa-2a plus ribavirin vs interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons
-
Chung RT, Andersen J, Volberding P, et al. 2004. Peginterferon alfa-2a plus ribavirin vs interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N. Engl. J. Med. 351:451-59
-
(2004)
N. Engl. J. Med
, vol.351
, pp. 451-459
-
-
Chung, R.T.1
Andersen, J.2
Volberding, P.3
-
41
-
-
4444270265
-
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV coinfected patients
-
Laguno M, Murillas J, Blanco JL, et al. 2004. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV coinfected patients. AIDS 18:F27-36
-
(2004)
AIDS
, vol.18
-
-
Laguno, M.1
Murillas, J.2
Blanco, J.L.3
-
42
-
-
1542378867
-
Peginterferon- alpha2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose
-
Hadziyannis SJ, Sette H Jr., Morgan TR, et al. 2004. Peginterferon- alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann. Intern. Med. 140:346-55
-
(2004)
Ann. Intern. Med
, vol.140
, pp. 346-355
-
-
Hadziyannis, S.J.1
Sette Jr., H.2
Morgan, T.R.3
-
43
-
-
33750587348
-
Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus coinfection
-
Lissen E, Clumeck N, Sola R, et al. 2006. Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus coinfection. AIDS 20:2175-81
-
(2006)
AIDS
, vol.20
, pp. 2175-2181
-
-
Lissen, E.1
Clumeck, N.2
Sola, R.3
-
44
-
-
3343006133
-
Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy
-
Mauss S, Valenti W, Depamphilis J, et al. 2004. Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy. AIDS 18:F21-25
-
(2004)
AIDS
, vol.18
-
-
Mauss, S.1
Valenti, W.2
Depamphilis, J.3
-
45
-
-
33748751179
-
Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons
-
Alvarez D, Dieterich DT, Brau N, et al. 2006. Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons. J. Viral Hepat. 13:683-89
-
(2006)
J. Viral Hepat
, vol.13
, pp. 683-689
-
-
Alvarez, D.1
Dieterich, D.T.2
Brau, N.3
-
46
-
-
0035956691
-
Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection
-
Lafeuillade A, Hittinger G, Chadapaud S. 2001. Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection. Lancet 357:280-81
-
(2001)
Lancet
, vol.357
, pp. 280-281
-
-
Lafeuillade, A.1
Hittinger, G.2
Chadapaud, S.3
-
47
-
-
0037340278
-
Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease
-
Neff GW, Bonham A, Tzakis AG, et al. 2003. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl. 9:239-47
-
(2003)
Liver Transpl
, vol.9
, pp. 239-247
-
-
Neff, G.W.1
Bonham, A.2
Tzakis, A.G.3
-
48
-
-
33751225955
-
Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic
-
Mehta SH, Lucas GM, Mirel LB, et al. 2006. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic. AIDS 20:2361-69
-
(2006)
AIDS
, vol.20
, pp. 2361-2369
-
-
Mehta, S.H.1
Lucas, G.M.2
Mirel, L.B.3
-
49
-
-
0028818269
-
Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR
-
Lanford RE, Chavez D, Von Chisari F, et al. 1995. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J. Virol. 69:8079-83
-
(1995)
J. Virol
, vol.69
, pp. 8079-8083
-
-
Lanford, R.E.1
Chavez, D.2
Von Chisari, F.3
-
50
-
-
0142178211
-
HCV persistence and immune evasion in the absence of memory T cell help
-
Grakoui A, Shoukry NH, Woollard DJ, et al. 2003. HCV persistence and immune evasion in the absence of memory T cell help. Science 302:659-62
-
(2003)
Science
, vol.302
, pp. 659-662
-
-
Grakoui, A.1
Shoukry, N.H.2
Woollard, D.J.3
-
51
-
-
19944432793
-
The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1
-
Kim AY, Lauer GM, Ouchi K, et al. 2005. The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1. Blood 105:1170-78
-
(2005)
Blood
, vol.105
, pp. 1170-1178
-
-
Kim, A.Y.1
Lauer, G.M.2
Ouchi, K.3
-
52
-
-
33845896269
-
Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection
-
Kim AY, Schulze zur WJ, Kuntzen T, et al. 2006. Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection. PLoS Med. 3:e492
-
(2006)
PLoS Med
, vol.3
-
-
Kim, A.Y.1
Schulze zur, W.J.2
Kuntzen, T.3
-
53
-
-
33847686361
-
CD4+ T cell-dependent reduction in hepatitis C virus-specific humoral immune responses after HIV infection
-
Netski DM, Mosbruger T, Astemborski J, et al. 2007. CD4+ T cell-dependent reduction in hepatitis C virus-specific humoral immune responses after HIV infection. J. Infect. Dis. 195:857-63
-
(2007)
J. Infect. Dis
, vol.195
, pp. 857-863
-
-
Netski, D.M.1
Mosbruger, T.2
Astemborski, J.3
-
54
-
-
33748077787
-
Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes
-
Balasubramanian A, Ganju RK, Groopman JE. 2006. Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes. J. Infect. Dis. 194:670-81
-
(2006)
J. Infect. Dis
, vol.194
, pp. 670-681
-
-
Balasubramanian, A.1
Ganju, R.K.2
Groopman, J.E.3
-
55
-
-
34249098017
-
Viral factors associated with cytokine expression during HCV/HIV co-infection
-
Blackard JT, Kang M, Clair JB, et al. 2007. Viral factors associated with cytokine expression during HCV/HIV co-infection. J. Interferon Cytokine Res. 27:263-70
-
(2007)
J. Interferon Cytokine Res
, vol.27
, pp. 263-270
-
-
Blackard, J.T.1
Kang, M.2
Clair, J.B.3
-
56
-
-
0034715950
-
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: The Swiss HIV Cohort Study
-
Greub G, Ledergerber B, Battegay M, et al. 2000. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 356:1800-5
-
(2000)
Lancet
, vol.356
, pp. 1800-1805
-
-
Greub, G.1
Ledergerber, B.2
Battegay, M.3
-
57
-
-
0037055011
-
Hepatitis C and progression of HIV disease
-
Sulkowski MS, Moore RD, Mehta SH, et al. 2002. Hepatitis C and progression of HIV disease. JAMA 288:199-206
-
(2002)
JAMA
, vol.288
, pp. 199-206
-
-
Sulkowski, M.S.1
Moore, R.D.2
Mehta, S.H.3
-
58
-
-
0036333636
-
Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system
-
Contreras AM, Hiasa Y, He W, et al. 2002. Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system. J. Virol. 76:8505-17
-
(2002)
J. Virol
, vol.76
, pp. 8505-8517
-
-
Contreras, A.M.1
Hiasa, Y.2
He, W.3
|